doses tirzepatide and Semaglutide key differences, weight loss results (2026) 3- Month Micro-dosing Tirzepatide |

We all want to lose weight, be healthy and live longer

Furthermore, we still recommend following guidance and requesting patients to stop GLP-1 RAs before elective surgery

Muscle loss is a documented risk during GLP-1 (Wegovy and Zepbound) use that requires active clinical management, not just weight tracking

This evaluation helps determine whether a medication is appropriate, which option may fit best, what dose strategy is safest, what monitoring is needed, and what support should be added to protect muscle, energy, digestion, hydration, and long-term outcomes

Get Started Clinically guided

Scientists are now investigating GLP-1s potential effectiveness against alcohol use disorder, opioid addiction, and nicotine dependence